Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Intarcia Therapeutics

24650 Industrial Boulevard
Hayward, CA 94545
(510) 782-7800
Website Company Summary Management Team

Management: Kurt Graves (President/CEO/Chairman) Thomas Alessi (VP Development & Manufacturing);  David J. Franklin (VP Commercial Operations) Anthony P. Hurley (VP Commercial Manufacturing and Operations) Sunita Zalani (VP Regulatory Affairs and Quality Assurance) Dick Ford (Executive Director of Manufacturing) Robert Lemmon (Executive Director of Regulatory Compliance & QA);  Michelle A. Baron (Chief Medical Officer) Owen Hughes (Chief Business Officer);  Matthew A. Dean (Sr. Director of Finance, Controller) James Ahlers (CFO) Raymond T. Keane (General Counsel)

Board: Glen Y. Sato (PDL BioPharma Former CFO)James Niedel (New Leaf Venture Partners Managing Director)Irwin Scher (Biosynexus CEO) Emad Rizk (Accretive Health CEO/President)Edward T. Mathers (NEA Partner) Michael G. Raab (NEA) Bryan E. Roberts (Venrock Associates)
Business Description

Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapies to enhance treatment outcomes by optimizing and improving the efficacy, eliminating the need for life-long injections, ensuring compliance and persistency over time with up to once-yearly dosing, and by improving the tolerability of drug therapies. Delivering medicines just once or twice yearly virtually ensures patient compliance and persistency, which is very poor in most chronic diseases. Intarcia's drug development expertise and competitive edge are demonstrated by its abilities to stabilize proteins and peptides at above-body temperature and to deliver them in a constant and consistent manner via Intarcia's proprietary technology platforms. Intarcia is conducting a Phase 3-stage development program for type 2 diabetes and has additional early development programs ongoing for weight regulation to control obesity. The company is HDQ in Boston, Mass.
Acquirer on  1  Companies

Phoundry Pharmaceuticals

Last Tweets


Last Mentions

Record updated: Sep 2015
Ownership: Private